Global Regenex provides consultation, case evaluation, and patient support in regenerative medicine, working with accredited hospitals in New Delhi, India.
We focus on:
* Autologous stem cell therapy
* Exosome-based supportive therapy
* Bone marrow transplant
* Cancer immunotherapy support
Our channel features:
1. Patient experience videos covering neurological, orthopaedic, infertility, eye, organ and bone marrow conditions
2. Condition-specific explainers
3. International patient guides, including country-specific support
4. Stem cell and regenerative medicine science explainers
Most stem cell and exosome-based approaches are investigational under current Indian medical guidelines and are not standard treatment for most conditions — we discuss this openly with every patient before any decision is made.
New Delhi, India │www.globalregenex.com│
📞 +91-78277-91242 📧 info@globalregenex.com
Subscribe for patient experiences and regenerative medicine science updates.
Global Regenex
World Patient Safety Day: Why Honesty Comes Before Treatment
Today is World Patient Safety Day — a reminder that safety should never take a back seat, especially in an evolving field like regenerative medicine.
Real patient safety isn't just about procedures done correctly — it's about honest evaluations, transparent conversations about risk, and never promising outcomes that can't be guaranteed.
At Global Regenex, patient safety guides every part of our approach. We conduct honest case evaluations before any treatment discussion and communicate clearly about what's proven versus investigational. As stem cell-based applications remain an evolving area of medicine, we focus on helping patients understand realistic expectations — not overstated claims.
Send your reports for review:
Email ID: info@globalregenex.com
Ph. no.: +91 7827791242
#WorldPatientSafetyDay #GlobalRegenex #StemCellTherapy #PatientSafety #HonestHealthcare #RegenerativeMedicine
3 days ago | [YT] | 1
View 0 replies
Global Regenex
Q: Diabetic and other forms of retinopathy progress differently in every patient. How does Global Regenex approach a case review?
A: By starting with retinal imaging, blood sugar control, and current visual function — never a one-size-fits-all answer. This is explored as a supportive option alongside standard ophthalmology and diabetes management.
Global Regenex specializes in evaluating complex and advanced-stage conditions, offering patients a thorough, evidence-based case review before any treatment discussion.
Send your retinal imaging and HbA1c for review:
Email ID: info@globalregenex.com
Ph. no.: +91 7827791242
Read more: www.globalregenex.com/stem-cell-treatment-for-reti…
#Retinopathy #GlobalRegenex #EyeHealth #StemCellTherapy #RegenerativeMedicine
1 week ago | [YT] | 1
View 0 replies
Global Regenex
Q: Not every liver disease patient is waiting on a transplant list. Who are the ones exploring a case review instead?
A: Usually, patients with early-to-moderate liver disease who've been told a transplant isn't yet necessary, or isn't yet accessible, and want a supportive option while managing the condition long-term. Child-Pugh (a medical system used to evaluate the severity and prognosis of chronic liver disease, especially cirrhosis ) and MELD (Model for End-Stage Liver Disease) scoring and imaging tell our hepatology-linked team where each patient stands.
Global Regenex specializes in evaluating complex, advanced-stage conditions like liver disease, offering patients a thorough, evidence-based case review before any treatment discussion.
Send your liver function scores for review:
Email ID: info@globalregenex.com
Ph. no.: +91 7827791242
Read more: www.globalregenex.com/stem-cell-treatment-for-live…
#LiverDisease #GlobalRegenex #StemCellTherapy #RegenerativeMedicine
2 weeks ago | [YT] | 0
View 0 replies
Global Regenex
Together, let's raise awareness and support better care for people living with spinal cord injuries.
This Spinal Cord Injury Awareness Month, we recognize the daily strength of patients and families navigating life after a spinal cord injury. Awareness is the first step — but real support means standing with patients through understanding, honest information, and access to the right care options.
Global Regenex is a research-focused platform based in New Delhi, India, offering consultation, case evaluation, and patient support in the field of regenerative medicine — including for patients living with spinal cord injuries.
Request a case-specific review:
Email ID: info@globalregenex.com
Ph. no.: +91 7827791242
#SpinalCordInjuryAwarenessMonth #GlobalRegenex #StemCellTherapy #SpinalCordInjuryAwareness #RegenerativeMedicine #SpinalCordInjury
2 weeks ago | [YT] | 0
View 0 replies
Global Regenex
Q: Spinocerebellar ataxia is genetic and progressive. Does that rule someone out of a case review?
A: Not automatically. The genetic subtype, current coordination and gait function, and rate of progression decide the answer, not the diagnosis alone. Most families come to us after standard neurology has plateaued and want a second, medically supervised opinion.
Global Regenex specializes in evaluating complex and advanced-stage conditions like glaucoma, offering patients a thorough, evidence-based case review before any treatment discussion.
Request a case-specific review:
Email ID: info@globalregenex.com
Ph. no.: +91 7827791242
Read more: www.globalregenex.com/stem-cell-treatment-for-spin…
#SpinocerebellarAtaxia #GlobalRegenex #StemCellTherapy #RegenerativeMedicine
3 weeks ago | [YT] | 1
View 0 replies
Global Regenex
Q: Glaucoma damage is often described as irreversible. So why do patients still request a case review?
A: Because they want to know if a supportive, investigational option can help alongside standard pressure-lowering treatment, not reverse damage already done. Visual field testing and current eye-pressure control are reviewed first.
Global Regenex specializes in evaluating complex and advanced-stage conditions like glaucoma, offering patients a thorough, evidence-based case review before any treatment discussion.
Send your visual field test for review:
Email ID: info@globalregenex.com
Ph. no.: +91 7827791242
Read more: www.globalregenex.com/stem-cell-treatment-for-glau…
#Glaucoma #GlobalRegenex #EyeHealth #StemCellTherapy #RegenerativeMedicine
3 weeks ago | [YT] | 2
View 0 replies
Global Regenex
Q: Sciatica often resolves on its own. What separates that from a case worth reviewing?
A: Duration and severity — persistent nerve pain, numbness, or weakness that hasn't responded to physiotherapy or standard pain management over a reasonable trial period. Nerve conduction studies and imaging are reviewed before anything else.
Request a nerve-and-imaging case review:
Email ID: info@globalregenex.com
Ph. no.: +91 7827791242
Read more: www.globalregenex.com/stem-cell-treatment-for-scia…
#SciaticNerve #GlobalRegenex #StemCellTherapy #RegenerativeMedicine #NervePain
3 weeks ago | [YT] | 1
View 0 replies
Global Regenex
Q: Chronic kidney disease has stages. Does the stage decide who's eligible for a case review?
A: Almost entirely — current eGFR, dialysis status, and underlying cause of kidney disease shape the whole conversation. This is discussed as supportive care alongside nephrology management, never as a replacement for dialysis or transplant.
Send your kidney function reports for review:
Email ID: info@globalregenex.com
Ph. no.- +91 7827791242
Read more: www.globalregenex.com/stem-cell-treatment-for-kidn…
#KidneyDisease #GlobalRegenex #StemCellTherapy #RegenerativeMedicine #NephrologyCare
4 weeks ago | [YT] | 1
View 0 replies
Global Regenex
Q: MS can be relapsing-remitting or progressive. Does that change who reaches out to Global Regenex?
A: Yes — most patients who contact us are already on a disease-modifying therapy and want to know if a supportive, investigational option fits alongside it, not instead of it. MRI and neurology reports decide what's even worth discussing.
Apply with your MRI and neurology reports:
Email ID: info@globalregenex.com
Ph. no.- +91 7827791242
Read more: www.globalregenex.com/stem-cell-treatment-for-mult…
#MultipleSclerosis #GlobalRegenex #MyelinHealth #SemCellTherapy #MS
1 month ago | [YT] | 1
View 0 replies
Global Regenex
Q: Complete or incomplete spinal cord injury — does that distinction actually change what's possible?
A: Yes, along with injury level and time since onset. Our neuro-rehab team weighs all three, since most patients who come to us are still in an active rehab window, chasing back function, not chasing a cure.
Apply for a neuro-rehab case review:
Email ID: info@globalregenex.com
Ph. no.- +91 7827791242
Read more: www.globalregenex.com/stem-cell-treatment-for-spin…
#SpinalCordInjury #GlobalRegenex #StemCellTherapy #Neurorehabilitation
1 month ago | [YT] | 1
View 0 replies
Load more